CY1120994T1 - Καινοτομες συνθεσεις διαλυματος που περιεχουν κυτταρικο παραγοντα και χρηση αυτων για τη θεραπεια τραυματων - Google Patents

Καινοτομες συνθεσεις διαλυματος που περιεχουν κυτταρικο παραγοντα και χρηση αυτων για τη θεραπεια τραυματων

Info

Publication number
CY1120994T1
CY1120994T1 CY181101323T CY181101323T CY1120994T1 CY 1120994 T1 CY1120994 T1 CY 1120994T1 CY 181101323 T CY181101323 T CY 181101323T CY 181101323 T CY181101323 T CY 181101323T CY 1120994 T1 CY1120994 T1 CY 1120994T1
Authority
CY
Cyprus
Prior art keywords
compositions containing
solution compositions
wound treatment
compositions
innovative solution
Prior art date
Application number
CY181101323T
Other languages
English (en)
Inventor
Vivienne S Marshall
Charlotte A Smith
Catherine J Trumpower
George L Sing
Linda O Palladino
Original Assignee
Noveome Biotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noveome Biotherapeutics Inc filed Critical Noveome Biotherapeutics Inc
Publication of CY1120994T1 publication Critical patent/CY1120994T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1891—Angiogenesic factors; Angiogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

Η εφεύρεση αφορά καινοτόμες συνθέσεις διαλύματος που περιέχουν κυτταρικό παράγοντα (αναφερόμενες στο παρόν ως συνθέσεις «CFS»), οι οποίες συμπεριλαμβάνουν καινοτόμες συνθέσεις διαλύματος παρατεταμένης αποδέσμευσης που περιέχουν κυτταρικό παράγοντα (αναφερόμενες στο παρόν ως συνθέσεις «SR-CFS»), μεθόδους παρασκευής των εν λόγω καινοτόμων συνθέσεων και χρήσεις αυτών.
CY181101323T 2007-08-22 2018-12-11 Καινοτομες συνθεσεις διαλυματος που περιεχουν κυτταρικο παραγοντα και χρηση αυτων για τη θεραπεια τραυματων CY1120994T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96570707P 2007-08-22 2007-08-22
US12596008P 2008-04-30 2008-04-30
PCT/US2008/009500 WO2009025730A1 (en) 2007-08-22 2008-08-08 Novel cellular factor- containing solution compositions

Publications (1)

Publication Number Publication Date
CY1120994T1 true CY1120994T1 (el) 2019-12-11

Family

ID=40378434

Family Applications (1)

Application Number Title Priority Date Filing Date
CY181101323T CY1120994T1 (el) 2007-08-22 2018-12-11 Καινοτομες συνθεσεις διαλυματος που περιεχουν κυτταρικο παραγοντα και χρηση αυτων για τη θεραπεια τραυματων

Country Status (11)

Country Link
US (11) US20090054339A1 (el)
EP (1) EP2185197B1 (el)
JP (1) JP2010536851A (el)
CN (2) CN104623669A (el)
CA (1) CA2696877A1 (el)
CY (1) CY1120994T1 (el)
DK (1) DK2185197T3 (el)
ES (1) ES2702809T3 (el)
PT (1) PT2185197T (el)
TR (1) TR201815580T4 (el)
WO (1) WO2009025730A1 (el)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1951327A2 (en) * 2005-11-17 2008-08-06 Biomimetic Therapeutics, Inc. Maxillofacial bone augmentation using rhpdgf-bb and a biocompatible matrix
EP2311505B1 (en) * 2006-02-09 2013-11-06 BioMimetic Therapeutics, LLC Compositions and methods for treating bone
US9161967B2 (en) 2006-06-30 2015-10-20 Biomimetic Therapeutics, Llc Compositions and methods for treating the vertebral column
US20100151025A1 (en) * 2007-02-20 2010-06-17 Biomimetic Therapeutics, Inc. Prevention and treatment for osteonecrosis and osteoradionecrosis of the jaw
US20100129328A1 (en) * 2007-07-24 2010-05-27 Sing George L Methods for promoting hair growth
WO2009025730A1 (en) * 2007-08-22 2009-02-26 Stemnion, Inc. Novel cellular factor- containing solution compositions
EP2620139B1 (en) 2008-02-27 2016-07-20 Biomet Biologics, LLC Interleukin-1 receptor antagonist rich solutions
US9480549B2 (en) 2008-04-25 2016-11-01 Allosource Multi-layer tissue patches
US9358320B2 (en) 2008-04-25 2016-06-07 Allosource Multi-layer tissue patches
CA2754501A1 (en) * 2009-03-05 2010-09-10 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods for the treatment of osteochondral defects
US20100239539A1 (en) * 2009-03-23 2010-09-23 Sing George L Methods for promoting differentiation and differentiation efficiency
CN107080834A (zh) 2010-02-22 2017-08-22 生物模拟治疗有限责任公司 用于治疗腱病的血小板衍生生长因子组合物和方法
US8313764B2 (en) 2010-06-22 2012-11-20 Stemnion, Inc. Wound healing device
US20120046601A1 (en) * 2010-08-23 2012-02-23 Sing George L Methods for delivering novel cell and cell-based compositions
EP2654434A4 (en) * 2010-12-20 2015-11-04 Stemnion Inc METHOD FOR TREATING TISSUE DISEASES, TROUBLES AND INJURIES
EP2663637B1 (en) * 2011-01-10 2017-09-27 Noveome Biotherapeutics, Inc. Accs for use in accelerating the healing of connective tissue injuries
CN103732234A (zh) * 2011-01-18 2014-04-16 斯丹姆涅恩有限公司 使伤口愈合的装置和方法
JP2014520857A (ja) * 2011-07-15 2014-08-25 アントフロゲネシス コーポレーション 羊膜由来接着細胞を使用する放射線障害の治療
US9162011B2 (en) 2011-12-19 2015-10-20 Allosource Flowable matrix compositions and methods
EP2850207B1 (en) * 2012-05-16 2017-01-04 Institut National de la Santé et de la Recherche Médicale (INSERM) Methods for the diagnosis and the treatment of familial thoracic aortic aneurysms caused by tgfb2 loss of function mutations
US8980251B2 (en) * 2013-02-23 2015-03-17 Stemnion, Inc. Methods for preventing and treating hemorrhoids
US20140242040A1 (en) * 2013-02-23 2014-08-28 Stemnion, Inc. Methods for preventing and/or treating nasal polyps and rhinosinusitis
US9186379B2 (en) * 2013-02-23 2015-11-17 Stemnion, Inc. Methods for preventing or treating necrotizing enterocolitis
US20140242043A1 (en) * 2013-02-23 2014-08-28 Stemnion, Inc. Methods for preventing or treating optic neuritis
US9446077B2 (en) 2013-03-13 2016-09-20 Allosource Fascia fibrous compositions and methods for their use and manufacture
WO2014164669A1 (en) 2013-03-13 2014-10-09 Stemnion, Inc. Improved medical device
US9486485B2 (en) * 2013-03-15 2016-11-08 Stemnion, Inc. Methods for treating urushiol-induced contact dermatitis
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
WO2014150784A1 (en) 2013-03-15 2014-09-25 Allosource Cell repopulated collagen matrix for soft tissue repair and regeneration
US9314487B2 (en) 2013-05-17 2016-04-19 Stemnion, Inc. Methods for treating cartilage disorders, diseases, and injuries
US20150051147A1 (en) * 2013-08-19 2015-02-19 Stemnion, Inc. Methods for treating hidradenitis suppurativa
US9636364B2 (en) 2013-12-04 2017-05-02 Stemnion, Inc. Methods for treating ocular contusion and blunt injury and traumatic injury to the optic nerve
EP3076982B1 (en) 2013-12-06 2020-02-19 Allosource Method of drying sheets of tissue
US20150335712A1 (en) 2014-05-21 2015-11-26 Stemnion, Inc. Treatment of Diseases and Conditions Caused by Increased Vascular Permeability
US20170267959A1 (en) 2014-11-25 2017-09-21 Corning Incorporated Cell culture media extending materials and methods
EP3317448B1 (en) 2015-06-30 2021-09-08 Tela Bio, Inc. Corner-lock stitch patterns
EP3324882B1 (en) 2015-07-21 2023-10-25 Tela Bio, Inc. Compliance control stitching in substrate materials
JP2018525360A (ja) * 2015-07-22 2018-09-06 テンプル ユニヴァーシティ − オブ ザ コモンウェルス システム オブ ハイアー エデュケーション 創傷治癒、組織工学、及び再生医療のための組成物及び方法における使用のための大豆由来の生物活性ペプチド
WO2017189772A1 (en) 2016-04-26 2017-11-02 Tela Bio, Inc. Hernia repair grafts having anti-adhesion barriers
US10772986B2 (en) 2017-01-26 2020-09-15 Allosource Fascia fibrous compositions and methods for their use and manufacture
US20180271914A1 (en) * 2017-03-21 2018-09-27 Noveome Biotherapeutics, Inc. Methods for Reducing the Extent of Light-induced Tissue Inflammation and Injury
KR102544417B1 (ko) 2017-03-31 2023-06-16 셀룸 바이오메디컬, 인크. 생체 적합성의 조건화된 세포 배지 조성물 및 그의 용도
KR102018609B1 (ko) * 2017-04-26 2019-09-06 이장호 중간엽 줄기세포 배양액을 포함하는 세포 또는 조직의 동결보존용 조성물
WO2019173792A1 (en) * 2018-03-09 2019-09-12 Tela Bio, Inc. Surgical repair graft
WO2020185688A1 (en) 2019-03-08 2020-09-17 Tela Bio, Inc. Textured medical textiles
US10758571B1 (en) 2019-04-09 2020-09-01 Combangio, Inc. Processes for making and using a mesenchymal stem cell derived secretome

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874746A (en) * 1987-12-22 1989-10-17 Institute Of Molecular Biology, Inc. Wound headling composition of TGF-alpha and PDGF
GB8803697D0 (en) * 1988-02-17 1988-03-16 Deltanine Research Ltd Clinical developments using amniotic membrane cells
DE4216341A1 (de) * 1992-05-16 1993-11-18 Roehm Gmbh Lichtstreuende Polymethacrylat-Formkörper mit hohen Temperatur- und Wetterechtheitswerten
US20030191061A1 (en) * 1994-03-31 2003-10-09 Brewitt Barbara A. Treatment methods using homeopathic preparations of growth factors
US20020192198A1 (en) * 1998-04-21 2002-12-19 Elia James P. Method for growing human organs and suborgans
JPH0912478A (ja) * 1995-04-25 1997-01-14 Fuji Yakuhin Kogyo Kk 新規な皮膚欠損症治療剤
US5612026A (en) 1996-01-25 1997-03-18 The Procter & Gamble Company Cholesterol lowering drink mix compositons
JP2000508922A (ja) * 1996-04-26 2000-07-18 ケース ウエスターン リザーブ ユニバーシティ 間葉幹細胞を用いる皮膚再生
US6393647B1 (en) * 2000-02-17 2002-05-28 The Libman Company Broom with mounting bracket for detachable handle
US7429378B2 (en) * 2003-05-13 2008-09-30 Depuy Spine, Inc. Transdiscal administration of high affinity anti-MMP inhibitors
GB2408207A (en) * 2003-11-24 2005-05-25 Johnson & Johnson Medical Ltd Wound dressing for the controlled release of therapeutic agents comprising also an inhibitor of a protease enzyme & a linker group cleavable by such an enzyme
DK1789534T3 (en) * 2004-08-16 2014-11-17 Cellres Corp Pte Ltd ISOLATION OF stem / progenitor cells FOSTER HINDE FROM an umbilical cord
CA2602684C (en) * 2005-03-31 2014-07-22 Stemnion, Inc. Amnion-derived cell compositions, methods of making and uses thereof
US8153430B2 (en) * 2005-03-31 2012-04-10 Stemnion, Inc. Methods related to surgery
US20060222634A1 (en) * 2005-03-31 2006-10-05 Clarke Diana L Amnion-derived cell compositions, methods of making and uses thereof
DE602006017705D1 (de) * 2005-06-16 2010-12-02 Wisconsin Alumni Res Found Zytotoxische ribonukleasevarianten
EP1904094A2 (en) * 2005-06-17 2008-04-02 Genentech, Inc. Use of vegf for wound healing
ES2331252T3 (es) * 2005-09-20 2009-12-28 Peter Jon Nelson Inhibidor tisular de metaloproteinasas (timp) unido a anclajes de glucosilfosfatidilinositol (gpi) para el tratamiento del cancer.
US8871198B2 (en) 2006-03-29 2014-10-28 Stemnion, Inc. Methods related to wound healing
US8475788B2 (en) * 2006-06-14 2013-07-02 Stemnion, Inc. Methods of treating spinal cord injury and minimizing scarring
EP2035093A4 (en) * 2006-06-14 2010-02-17 Stemnion Inc METHODS FOR TREATING SPINAL CORD INJURY AND MINIMIZING THE SCALING SCALE
WO2009008928A2 (en) * 2007-04-13 2009-01-15 Stemnion, Inc. Methods for treating nervous system injury and disease
US20090004161A1 (en) * 2007-06-26 2009-01-01 Palladino Linda O Methods for treating pustular conditions of the skin
WO2009025730A1 (en) * 2007-08-22 2009-02-26 Stemnion, Inc. Novel cellular factor- containing solution compositions

Also Published As

Publication number Publication date
ES2702809T3 (es) 2019-03-05
DK2185197T3 (en) 2018-12-10
US8283316B2 (en) 2012-10-09
CN101815531A (zh) 2010-08-25
PT2185197T (pt) 2019-01-21
US20130040880A1 (en) 2013-02-14
US8088732B2 (en) 2012-01-03
US20120225048A1 (en) 2012-09-06
CN101815531B (zh) 2015-01-14
JP2010536851A (ja) 2010-12-02
US20130302307A1 (en) 2013-11-14
EP2185197A4 (en) 2011-11-23
US9173927B2 (en) 2015-11-03
EP2185197B1 (en) 2018-10-17
US20120238495A1 (en) 2012-09-20
US20120101036A1 (en) 2012-04-26
US8318672B2 (en) 2012-11-27
TR201815580T4 (tr) 2018-11-21
WO2009025730A1 (en) 2009-02-26
US8530418B2 (en) 2013-09-10
CN104623669A (zh) 2015-05-20
US8318665B1 (en) 2012-11-27
US20120225815A1 (en) 2012-09-06
US20120322731A1 (en) 2012-12-20
US8058066B2 (en) 2011-11-15
US8198239B2 (en) 2012-06-12
US8822415B2 (en) 2014-09-02
US20090054339A1 (en) 2009-02-26
US20150025007A1 (en) 2015-01-22
US20100144604A1 (en) 2010-06-10
EP2185197A1 (en) 2010-05-19
US20100075905A1 (en) 2010-03-25
US8278417B2 (en) 2012-10-02
CA2696877A1 (en) 2009-02-26

Similar Documents

Publication Publication Date Title
CY1120994T1 (el) Καινοτομες συνθεσεις διαλυματος που περιεχουν κυτταρικο παραγοντα και χρηση αυτων για τη θεραπεια τραυματων
CY1119669T1 (el) Παραγωγα 1-φαινυλ-2-πυριδινυλ-αλκυλ-αλκοολων ως αναστολεις φωσφοδιεστερασης
CY1117615T1 (el) Ενωσεις θειαζολης σουλφοναμιδης και οξαζολης
CY1115199T1 (el) Κυτταροτοξικοι παραγοντες που περιεχουν νεα παραγωγα τομαϋμυκινης και η θεραπευτικη τους χρηση
CY1109010T1 (el) γ-ΚΡΥΣΤΑΛΛΙΚΗ ΜΟΡΦΗ ΤΗΣ ΥΔΡΟΧΛΩΡΙΚΗΣ ΙΒΑΒΡΑΔΙΝΗΣ, ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΤΗΣ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΤΗΝ ΠΕΡΙΕΧΟΥΝ
CY1115176T1 (el) Ρυθμιστες υποδοχεων τυπου toll
CY1118007T1 (el) Μεθοδοι για την χορηγηση υπογλυκαιμικων μεσων
SE0301700D0 (sv) Novel compounds
CY1115087T1 (el) Παραγωγα αμινο-πυριδινων ως αγωνιστες των υποδοχεων s1p1/edg1
CY1112019T1 (el) Αγωνιστες υποδοχεων νιασινης, συνθεσεις που περιεχουν τετοιες ενωσεις και μεθοδοι θεραπειας
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
CY1113282T1 (el) Αντιικα νουκλεοζιτικα αναλογα
CY1113159T1 (el) Ανταγωνιστες υποδοχεα γλυκαγονης, παρασκευη και θεραπευτικες χρησεις
CY1105362T1 (el) Παραγωγα σουλφοναμιδιου, η παρασκευη τους και η εφαρμογη αυτων ως φαρμακα
CY1113267T1 (el) Παραγωγα θειοφαινιου ως αγωνιστες των υποδοσεων s1p1/edg1
CY1114669T1 (el) Υποκατεστημενα παραγωγα σουλφοναμιδιου
CY1110965T1 (el) Επιπροσθετες ετεροπολυκυκλικες ενωσεις και η χρηση τους ως ανταγωνιστες μεταβολοτροπικου υποδοχεα γλουταμικου
CY1114539T1 (el) Η χρησιμοτητα των ιμιδαζοπυριδαζινοκαρβονιτριλιων ως αναστολεων κινασων
CY1109998T1 (el) Ενδυναμωτες υποδοχεων γλουταμινικου
CY1113533T1 (el) Ετεροαρυλο-υποκατεστημενα παραγωγα κυκλοεξυλο-1,4-διαμινης
BRPI0418251C1 (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo
CY1112653T1 (el) Κρυσταλλικες τροποποιησεις της πυρακλοστροβινης
CY1113963T1 (el) Φαρμακευτικες συνθεσεις οι οποιες περιλαμβανουν ανταγωνιστες ακτιβινης-actriia και χρηση αυτων στην προληψη η' θεραπευτικη αγωγη πολλαπλου μυελωματος
UA112281C2 (uk) Стабільні інсектицидні композиції і способи їх отримання
CY1108067T1 (el) Υποκατεστημενα παραγωγα 2-πυριδινο-κυκλοεξανο-1,4-διαμινης